In the first installment of MIA's Unheard Voices series, Carlton Brown talks about his life, living on the streets, the psychiatric system, and survival.
The "science" of happiness has always been inextricably linked to eugenics. Modern positive psychology, with its focus on genetics and willpower, is no different.
Richard Sears interviews Marcella Ot’alora, therapist and principal investigator for MAPS MDMA-assisted psychotherapy.
Dr. Rush talks about the THEN Center and the links between childhood trauma, inequality, human development, and chronic illness.
Peer-Support Groups Were Right, Guidelines Were Wrong: Dr. Mark Horowitz on Tapering Off Antidepressants
In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.
In 2008, a reviewer of psychiatric drugs at the FDA, Ron Kavanagh, complained to Congress that the FDA was approving a new antipsychotic that was ineffective and yet had adverse effects that increased the risk of death. Twelve years later, a review of the whistleblower documents reveal an FDA approval process that can lead to the marketing of drugs sure to harm public health.
The World Health Organization newly published guidance for community mental health urges an end to forced treatment and the adoption of person-centered and rights-based services.
The proponents of compulsory outpatient treatment claim that it leads to better outcomes for the recipients, and protects society from violent acts by the "seriously mentally ill." Those claims are belied by history, science, and a critical review of the relevant research.
Richard Sears interviews Ilana Mountian on drug use, marginalization, the disease model of addiction, and problems with prohibition.
Comparing her circumstances to sex trafficking, Britney Spears told the judge she wished to sue her conservators and be allowed to tell reporters “what they did to me.”
Greg Hitchcock is standing and schmoozing with a cluster of people in the soaring, glass-domed rotunda of what once was a grand old bank...
Hanna Pickard on the elusive middle ground between personal responsibility and systemic factors in our understandings of addiction.
Every year suicide hotline centers covertly trace tens of thousands of confidential calls, and police come to homes, schools, and workplaces to forcibly take callers to psychiatric hospitals.
MIA's Ana Florence interviews Michelle Funk about her leadership of the new WHO guidelines on rights-based mental health.
Soon after states finally began providing adults who remembered childhood abuse with the legal standing to sue, the FMSF began waging a PR campaign to discredit their memories—in both courtrooms and in the public mind.
The American Psychiatric Association and its former president, Jeffrey Lieberman, have used the Goldwater Rule to try to silence Yale psychiatrist Bandy Lee and colleagues who warned, in a collection of essays, about why President Trump is "dangerous." Why would a guild choose to do this?
A new questionnaire funded by AbbVie conflates antidepressant side effects with bipolar disorder and doesn’t actually meet the criteria for being considered “screening.”
That is the truth about withdrawal syndrome: It’s like a 50-50 chance that you’re going to have a problem. If you’re in the unlucky half, you’re gonna be really unlucky.
At the Hurdalsjøen Recovery Center in Norway, patients with a long history of psychiatric hospitalizations are tapering from their medications and, in a therapeutic environment that emphasizes a good diet, exercise, and asking patients "what do they want in life," are leaving their old lives as chronic patients behind.
MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.
The Ministry of Health in Norway has ordered its four regional health authorities to offer medicine-free treatment in psychiatric hospitals. A six-bed ward in Tromso, which is in the far north of Norway, is now providing such care.
The FDA recently approved lumateperone for schizophrenia. A review of the clinical trials reveals a testing process that is fatally flawed, and a new drug coming to market that doesn't provide a clinically meaningful benefit.
Richard Sears interviews transpersonal psychologist Katrina Michelle about harm reduction practices with psychedelics in therapy.
Ayurdhi Dhar interviews Tanya Luhrmann about cultural differences in voice-hearing, diagnosis and damaged identities, and conflicts in psychiatry.
Psychiatry has long turned a blind eye to the full scope of harm associated with TD. New TD drugs "work" by further impairing brain function.